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According to current models (D'Arcangelo et al., 1999;
Hiesberger et al., 1999; Senzaki et al., 1999), Reelin acts
by binding to a complex of receptor proteins on the
migrating neuron, which includes nonclassical cadher-
ins (CNRs) and a pair of redundant receptors, the ApoE
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receptor 2 (ApoER2) and the VLDL receptor (VLDLR).Program in Developmental Biology
Binding of Reelin causes the ApoE and VLDL receptorsFred Hutchinson Cancer Research Center
to recruit an intracellular adaptor protein, Disabled (inSeattle, Washington 98109
mice called mDab1, but simply referred to as Dab hereaf-
ter), and this becomes phosphorylated on tyrosine resi-
dues, perhaps by a CNR-associated Src family protein
Alzheimer's disease (AD) is the most common senile tyrosine kinase. Phosphorylation of Dab somehow
dementia in the elderly. The disease is characterized causes the migrating neuron to cease migrating, release
behaviorally by global cognitive decline, and defined from its substratum, the radial glial cell, and begin to
histologically by two distinguishing pathologies: amy- differentiate. This picture is supported by the observa-
loid plaques, which are extracellular deposits consisting tion that mutations in Dab or a double mutant in ApoER2
mainly of aggregated b-amyloid peptide, and neurofibril- and VLDLR give phenotypes identical to that of Reelin
lary tangles, which are intracellular deposits consisting mutants, and by biochemical analysis of Reelin signal-
predominantly of hyperphosphorylated tau protein. A ing. Moreover, genetic ablation of Reelin or the ApoE
central direction in efforts to understand AD has been to receptors eliminates Dab phosphorylation and leads to
identify genetic mechanisms that predispose individuals dramatic upregulation of Dab levels. Together, these
to developing the disease. Most notably, familial AD data suggest that Dab either mediates or regulates sig-
frequently results from mutations in genes encoding the naling by Reelin receptors in cortical development.
b-amyloid peptide precursor protein bPP or genes en- CDK5 as a Downstream Element Controlling
coding presenilins, which are responsible for processing Migration of Cortical Neurons
of bPP. Also, specific alleles of Apolipoprotein E (ApoE) It is clear that Reelin, ApoER2/VLDLR, and Dab are re-
increase the risk of developing sporadic forms of AD, quired for the transmembrane signaling that establishes
and influence the age of onset of familial AD. However, the pattern of cortical neuron migration, but how the
these discoveries have not yet provided a clear under- signal is propagated downstream of Dab is much less
standing of the molecular mechanism of the disease, clear. One strong hint comes from the observation that
nor have they revealed the nature of the connection mutations in the gene encoding the serine/threonine
between its twin hallmarks, plaques and tangles. protein kinase CDK5, or in its activating subunit p35,
Surprisingly, several of the genes and proteins associ- produce defects in cortical neuron migration that resem-
ated with AD have recently been found to play central ble those caused by loss of the Reelin signal (Chae et
roles in early neural development, particularly neuronal al., 1997). Might CDK5/p35 therefore be a downstream
migration and axon extension. Although the potential element in signaling by Reelin/ApoER2-VLDLR/Dab?
significance of this observation has not escaped the Several lines of evidence are consistent with this conjec-
attention of investigators, no coherent picture has yet ture. In particular, the Abl protein tyrosine kinase, which
emerged of the relationship between neurodevelopmen-
tal and neurodegenerative mechanisms. In this review,
we discuss the normal physiological functions ascribed
to some of the AD-associated genes. These functions
highlight intracellular signaling pathways that may link
many of the proteins implicated genetically in AD. Such
pathways might provide a useful context within which
to consider AD pathology.
Reelin-Dependent Transmembrane Signaling
in Migration of Cortical Neurons
Cortical neurons are born deep inside the brain, in the
ventricular germinal zone beneath the cortical plate (Fig-
ure 1). They migrate radially outward along radial glia,
past earlier-born neurons, until they reach the outermost
layer of the brain, the ªCajal-Retziusº cells. At this point
the migrating neurons stop, exit the radial glial ªtrack,º
Figure 1. Influence of Reelin Pathway Mutations on Neocorticaldifferentiate and extend axonal and dendritic processes.
LaminationThe orderly migration of nascent neurons is guided by
In normal cortical development (left) neuronal precursors leavinga protein, Reelin, which is secreted by Cajal-Retzius
the ventricular proliferative zone migrate through neurons generatedcells. In the absence of Reelin, radially migrating cortical
previously, generating a laminated structure in which younger neu-
neurons fail to pass through the layer of early-born sub- rons surmount older ones. Absence of Reelin secretion from Cajal-
plate neurons and ªpile upº in a disordered manner. Retzius cells (CR), or inability of neuronal precursors to respond to
Reelin, causes abnormal cortical development (right) with disor-
dered lamination, and with older neurons lying below early-born³ To whom correspondence should be addressed (e-mail: mab@
u.washington.edu). subplate neurons, rather than above them.
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Figure 2. Proteins and Signaling Pathways
Implicated in Cortical Development and in
Alzheimer's Disease
The figure depicts various proteins and sig-
naling pathways implicated in developmental
regulation of migration of neuronal precur-
sors, and regulation of axonal and dendritic
growth. Black represents proteins that have
been unequivocally implicated in AD by ge-
netic studies, and gray denotes proteins im-
plicated by a single genetic study or where
results of several studies have conflicted.
Blue denotes proteins linked to AD by bio-
chemical evidence. Red arrows depict vari-
ous characteristics of AD that are plausibly
dependent on the activity of Rac and CDK5.
For simplicity, the various membrane proteins
are shown within the same membrane. How-
ever, the precise membrane pool within which
these proteins act is a subject of controversy,
and all proteins shown may not act within the
same membrane pool.
signals in concert with Dab in Drosophila, phosphory- central to AD, as mutations identified by positional clon-
lates and activates the kinase activity of mammalian ing in cases of familial AD represent either mutations in
CDK5 (Zukerberg et al., 2000). Furthermore, Rac, which bPP or, more commonly, mutations in Presenilin-1 or
also is implicated in Abl signaling both in Drosophila Presenilin-2 that influence the position and/or efficiency
and in mammals, exists in a complex with CDK5 and of bPP cleavage. However, the possibility that bPP also
promotes CDK5 activation (Nikolic et al., 1998). Finally, has receptor-like functions involving signaling through
CDK5/p35 is an important mediator of tau phosphoryla- its cytosolic domain has not entirely escaped consider-
tion (Patrick et al., 1999), and mutation of Reelin or ation.
ApoER2 and VLDLR substantially induces phosphoryla- Notch proteins provide a useful model for thinking
tion of tau (Hiesberger et al., 1999). about the potential consequences of bPP processing.
Relationship of Cell Migration and Axon Extension The Notch proteins are a ubiquitous family of type I
Genes to Neurodegeneration and AD? membrane receptors for ligands of the Delta/Serrate
A recent report indicates that inappropriate activation family. Binding of ligand to Notch induces sequential
of CDK5 can cause neural degeneration and that p25, proteolysis of Notch at two sites. Cleavage by the en-
a deregulated proteolytic fragment of p35, accumulates zyme TACE in the Notch extracellular domain is followed
in degenerating portions of AD brain, upregulating CDK5 by Presenilin-dependent cleavage of the Notch mem-
kinase activity and leading to tau phosphorylation (Pat- brane-spanning segment, thus releasing the intracellular
rick et al., 1999). If CDK5 contributes to the pathology domain of the protein from the membrane. The released
of AD, could it be that Dab-dependent signaling mecha- Notch intracellular fragment, associated with the DNA
nisms impact on CDK5 function in AD as they do in binding protein Su(H), then enters the nucleus, where it
cortical development? Tantalizing evidence hints that activates the transcription of target genes. A second,
this may be true (Figure 2). The epsilon4 allele of ApoE, probably parallel, Notch signaling pathway has also
an alternative ligand for the Dab1-coupled receptors been described (Giniger, 1998). In Drosophila axons,
ApoER2 and VLDLR, is a risk factor for AD, and neuronal Notch cooperates with the Abl tyrosine kinase to directly
expression of human epsilon4-ApoE in transgenic mice control growth cone motility and guidance, and this
causes hyperphosphorylation of tau (Tesseur et al.,
seems to be mediated by recruitment of the Abl-associ-2000). As discussed above, CDK5/p35 is an important
ated adaptor protein, Disabled. Abl and Disabled, in turn,mediator of tau phosphorylation. Moreover, genetic as-
appear to regulate Drosophila growth cone function viasociation with AD has been reported for two Dab-linked
the Rho family GTPases, particularly Rac, and the RacreceptorsÐthe VLDLR receptor and another apoE re-
GEF, Trio (Liebl et al., 2000). The latter pathway mayceptor called LRP. Furthermore, bPP, which has a re-
serve as a useful model for the putative pathway linkingceptor-like structure, is also capable of binding Dab
ApoE receptor signaling to tau phosphorylation in AD.(Trommsdorff et al., 1998). A second LRP ligand, a2-
Remarkably, Notch also serves as an informativemacroglobulin also has a genetic association with AD
model of bPP proteolytic processing (reviewed by(Blacker et al., 1998). Although it has not been estab-
Brown et al., 2000). Like Notch, bPP undergoes twolished that the binding interactions between LRP, bPP,
sequential cleavages, an initial cleavage in the extracel-and Dab are functionally important, it is tempting to
lular domain near the membrane, and a second cleavagespeculate that signaling pathways emanating from ApoE
within the membrane spanning sequence. The secondreceptors and/or bPP influence Dab and thus CDK5
cleavage is performed by a Presenilin-dependent prote-activity.
ase (g-secretase) that is perhaps identical to that em-Functional Consequences of bPP Proteolysis:
ployed by Notch. The initiating cleavage in bPP occursNotch as a Model for bPP
at two alternative sites, one employing an a-secretaseA main thrust of modern AD research has been directed
activity identical to the TACE enzyme that cleavesat understanding the functional consequences of gener-
Notch, the other employing a b-secretase activity pro-ation of extracellular b-amyloid peptide from bPP. Com-
pelling evidence indicates that proteolysis of bPP is vided by the enzyme BACE. Notch and bPP represent
Minireview
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examples of a growing list of proteins undergoing mech- intracellular signal transduction pathway by a variety of
upstream stimuli could potentially unify a large bodyanistically similar ªregulated intramembrane proteoly-
sisº (RIP; Brown et al., 2000). Remarkably, in every in- of seemingly unrelated observations. For example, the
stance of RIP, with the possible exception of bPP, the suggestion that Rac activation is a central point of con-
cytosolically released peptide enters the nucleus as a vergence of these signaling pathways could account for
transcriptional regulator. the reactive oxygen pathways invoked by innumerable
The various bPP and Presenilin mutations occurring studies of AD, as Rac is an essential mediator of produc-
in familial AD either increase the net rate of b-amyloid tion of superoxide in a variety of systems (reviewed by
peptide release or subtly alter the cleavage site, produc- Goldschmidt-Clermont and Moldovan, 1999). Rac also
ing a greater proportion of a more amyloidogenic 42 promotes activation of Jun kinase, a known stimulator of
residue peptide compared to the less amyloidogenic 40 neuronal apoptosis (Minden et al., 1995). Finally, CDK5,
residue peptide (Hardy et al., 1998). These differences Rac, Dab, and Notch are all known to be important
presumably account for the observed pathology. How- regulators of axonal and dendritic growth (for example,
ever, these differences in the N-terminal bPP cleavage see Giniger, 1998; Patrick et al., 1999; Sestan et al.,
product must inevitably be accompanied by parallel 1999), potentially accounting for the aberrant neurite
changes in the quantity or sequence of the cytosolically sprouting that is prominent in AD.
released carboxy-terminal domain. The cytosolically re- Reagents exist to address the many questions raised
leased peptide may be physiologically irrelevant, as it by the preceding discussion. Do CDK5/p35 and Rac
has never been observed to accumulate in biochemi- function downstream of ApoE receptors in cortical lami-
cally or immunocytochemically detectable quantities. nation and/or AD? Does the cytosolic domain of bPP
However, the functionally critical nuclear fragment of participate in physiologically relevant intracellular sig-
wild-type Notch cannot typically be detected by such naling? Does a dab mutation protect against (or en-
methods either (Schroeter et al., 1998; Struhl and Ada- hance?) neuronal cell death in AD models, either in vivo
chi, 1998). The amino acid sequence of the intracellular or in vitro? The relationship among the pieces of the AD
domain of bPP has been conserved without any alter- puzzle is still unclear, but there is reason to hope that
ation through evolution of mammals and birds, sug- clarity is within reach.
gesting important and rigidly defined functions beyond
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